Targeting transcription in heart failure via CDK7/12/13 inhibition
Austin Hsu(Gladstone Institutes), Saptarsi M. Haldar(Amgen (United States)), Yanke Liang(Harvard University), Qiming Duan(Shanghai University), Nathanael S. Gray(Stanford University), Zachary B. Feldman(Vanderbilt University Medical Center), Arun Padmanabhan(Gladstone Institutes), Charles Y. Lin(Kronos Bios (United Kingdom)), Michael Alexanian(Gladstone Institutes), Yu Huang(Gladstone Institutes), Xin Luo(Guizhou University), Jonathan D. Brown(Vanderbilt University), Zhen Jiang(Amgen (United States)), Tinghu Zhang(Stanford University), Daniel S. Day(Center for Systems Biology), Benoit G. Bruneau(Council of Science Editors), Richard A. Young(Whitehead Institute for Biomedical Research), Sarah McMahon(Gladstone Institutes)
Cited by 16
Related Papers
A Landscape of Pharmacogenomic Interactions in Cancer
|Cell|2016|2.3k
An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
|Journal of Biological Chemistry|2009|1.8k
Targeted Recruitment of Set1 Histone Methylase by Elongating Pol II Provides a Localized Mark and Memory of Recent Transcriptional Activity
|Molecular Cell|2003|1.1k
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848